The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
Michael Schieber, Shuo Ma Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA Abstract: The BCL-2 protein family members inhibit cellular apoptosis, and their overexpression repre...
Guardado en:
Autores principales: | Schieber M, Ma S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bda0a302eee5436c9798e812c776575e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015) -
Targeting CD20 in chronic lymphocytic leukemia
por: Nahas MR, et al.
Publicado: (2015) -
Coexistence of primary myelofibrosis and chronic lymphocytic leukemia
por: Burgstaller S, et al.
Publicado: (2014) -
Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia
por: O'Brien S, et al.
Publicado: (2012) -
Treating the elderly patient with chronic lymphocytic leukemia: current and emerging options
por: Mozaheb Z
Publicado: (2014)